(Q44501609)

3 December 2017

title

Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children (English)

1 reference

3 December 2017

4

Hester E de Melker

1 reference

3 December 2017

Jeanet M Kemmeren

1

1 reference

3 December 2017

Sylvana S Timmer

series ordinal

2

1 reference

3 December 2017

Nicoline A T van der Maas

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

22 April 2011

1 reference

3 December 2017

1 reference

3 December 2017

volume

29

1 reference

3 December 2017

issue

26

1 reference

3 December 2017

page(s)

4373-4377

1 reference

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Systematic review of the effects of pertussis vaccines in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.009

10.1016/J.VACCINE.2011.04.009

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference